Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy.
Eur J Ophthalmol
; 21(4): 503-5, 2011.
Article
em En
| MEDLINE
| ID: mdl-21279982
ABSTRACT
PURPOSE:
To report the anatomic and functional outcome of intravitreal bevacizumab (IVB) to treat choroidal neovascularization (CNV) following photodynamic therapy (PDT) to treat recurrent central serous choroidopathy (CSC).METHODS:
This was an interventional case report in which verteporfin PDT was performed in a case of recurrent CSC.RESULTS:
Following PDT, the patient developed juxtafoveal CNV that was later treated by IVB, achieving CNV closure and recovery of visual acuity.CONCLUSIONS:
Photodynamic therapy is a useful therapy to treat recurrent CSC, though it may be associated with potentially severe complications such as CNV. Intravitreal bevacizumab seems a good alternative treatment in the management of this condition.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fotoquimioterapia
/
Neovascularização de Coroide
/
Inibidores da Angiogênese
/
Coriorretinopatia Serosa Central
/
Anticorpos Monoclonais Humanizados
Tipo de estudo:
Etiology_studies
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Eur J Ophthalmol
Assunto da revista:
OFTALMOLOGIA
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
Espanha